Abstract

 
 
 
 Purpose: To investigate the anti-proliferative effect of cynaropicrin on lung cancer cell lines, and the underlying molecular mechanism.
 Methods: The effect of cynaropicrin treatment on the viabilities of H1975 and H460 cells was measured using Cell Counting Kit-8. Apoptosis was analysed by annexin-V/FITC staining, while protein expressions were assayed by western blotting.
 Results: Treatment of H1975 and H460 cells with cynaropicrin at doses of 0.25 – 2.0 μM led to a marked reduction in their viability (p < 0.05). In cynaropicrin-treated H1975 and H460 cells, there was significant increase in apoptosis, when compared to control cells. Caspase-3 and caspase-9 levels were also significantly increased in H1975 and H460 cells on treatment with cynaropicrin at doses of 0.25 and 2.0 μM while treatment with cynaropicrin at doses of 0.25 - 2.0 μM significantly down-regulated the mRNA expression of CCND1 in the two cell lines (p < 0.05). Cynaropicrin markedly inhibited mRNA and protein expressions of EGFR, and also downregulated AKT in H1975 and H460 cells (p < 0.05). However, cynaropicrin significantly increased the expressions of miR-202 and miR-370.
 Conclusion: Cynaropicrin exerts anti-proliferative and proapoptotic effects on H1975 and H460 lung cancer cells via deactivation of EGFR/AKT signaling pathway. Moreover, it upregulated the expressions of miR-202 and miR-370 in these cells. Thus, cynaropicrin has potentials for the treatment of lung cancer.
 
 
 
Highlights
Despite advancements in diagnosis and treatment technologies, lung cancer still remains a leading cause of cancer-related mortalities worldwide [1,2]
Overexpression of miR-202 leads to arrest of cell cycle, followed by activation of apoptosis through cyclin D1 (CCND1) inhibition in cancer cells [8,9]
The present study investigated the anti-proliferative potential of cynaropicrin in lung cancer cells, as well as the associated molecular mechanism
Summary
Despite advancements in diagnosis and treatment technologies, lung cancer still remains a leading cause of cancer-related mortalities worldwide [1,2]. Overexpression of miR-202 leads to arrest of cell cycle, followed by activation of apoptosis through cyclin D1 (CCND1) inhibition in cancer cells [8,9]. Overexpression of miR-202 in pulmonary cancer cells has been associated with inhibition of proliferation through suppression of the expression of signal transducer and activator of transcription (STAT3) [8,9]. The present study investigated the anti-proliferative potential of cynaropicrin in lung cancer cells, as well as the associated molecular mechanism. Statistical analysis caspase-3 and caspase-9 were increased significantly in H1975 and H460 cells on treatment with cynaropicrin at doses of 0.25 and 2.0 μM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have